It turns out that Cochrane’s for Christmas, not just for life, with evidence in the Cochrane Library on all manner of festive things from gold, frankincense and myrrh to stockings! Ok, some of the links are a bit tenuous, but we hope you’ll enjoy our advent calendar.
Owing to some trouble with the technology elves, we couldn’t make it interactive (boo!) but each day we’ll post some Cochrane evidence related to the day’s picture, below the calendar. If you think of any others, do share them via the comments box.
Key message: Limited evidence suggests that a Mediterranean dietary pattern reduces some cardiovascular disease (CVD) risk factors. Existing evidence is promising but more trial evidence is needed to establish the role of the Mediterranean dietary pattern in preventing CVD in the general population and high-risk individuals.
Back in 1970s Britain, I grew up with a Mediterranean diet, thanks to my French step-father, though I didn’t always appreciate it. Strawberry Mivvis for my friends, something (everything?!) in olive oil for me. I particularly hated a concoction called tian, which combined courgettes, eggs and rice to produce something truly unpleasant, particularly when served cold. In 21st century Britain, Marseilles has come to Morrisons and many of us eat Med-style. We hear much conflicting advice about what we should and shouldn’t eat, the benefits of this over that, so I was interested in the latest Cochrane evidence on the so-called Mediterranean diet. Continue reading →
Probably not, but it could increase your chance of baldness! Selenium is a trace element which is involved with thyroid hormone metabolism, the immune system and also glass making and electronics! It is available to buy as a supplement over the counter, but it is also found naturally in brazil nuts, fish, shellfish and grains. It has become popular in recent years as it has been thought to work as an antioxidant. A new review from the Cochrane Heart Group assessed the effect of this supplement on healthy adults, to test whether it prevented heart attacks. Continue reading →
Atrial fibrillation (AF) is the most common rhythm disturbance of the heart. It involves the top two chambers of the heart quivering (fibrillating) rather than beating effectively. This can lead to three potential problems: Firstly, without the top two chambers pumping properly the heart becomes less effective at pumping. This can make some patients feel tired or more breathless during exercise. Secondly, in some cases, the bottom two chambers of the heart try their best to keep up with the fast quivering of the top two chambers, leading them to beat faster than they normally would. This can make some people feel their heart pounding in their chest (palpitations), or tired or breathless on exertion. Thirdly, patients are more likely to have a stroke. This is because the blood moves more sluggishly through the quivering chambers and has an increased tendency to form blood clots. These can lodge in arteries in the brain, starving that area of blood and oxygen. Continue reading →
Given that February is National Heart Month (cue Valentine’s Day), I thought I would blog about a recent Cochrane review by the Cochrane Heart Group which has just been published, all about statins. Statins are a family of medicines prescribed for lowering cholesterol. They are one of the most commonly prescribed medicines, particularly by us cardiologists and our GP colleagues. The number of prescriptions and cost to the NHS of these drugs has grown significantly in the last few years, from £20 million in 1993 to £500 million in 2006. They are frequently prescribed for preventing further heart attacks and strokes when a patient has already had one (called secondary prevention by us doctors) but the evidence of benefit when given to patients to prevent a first heart or stroke (called primary prevention) is less clear. This review aimed to assess the effects, both harms and benefits, of statins in people with no history of cardiovascular disease. Continue reading →
Key message: There is not enough evidence to show whether 10mg or 5mg loading dose of warfarin is safer or quicker. It may be more appropriate to use smaller doses in elderly patients. Continue reading →